The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Paratek Pharmaceuticals, Inc(NASDAQ:PRTK) 
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, ...
Paratek Pharmaceuticals Days Payable Outstanding ttm (DPO)
Paratek Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Paratek Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Paratek Pharmaceuticals Op Cashflow Per Share ttm
Paratek Pharmaceuticals Free Cashflow Per Share ttm
Paratek Pharmaceuticals Cash Per Share ttm
Paratek Pharmaceuticals P/S ratio ttm
Paratek Pharmaceuticals (GAAP) P/E ratio ttm
Paratek Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.